$SSOK
Sunstock, Inc.

2024 Q1 Form 10-Q Financial Statement

#000149315224019643 Filed on May 15, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q1
Revenue $282.1K $3.340M
YoY Change -91.55% 2.8%
Cost Of Revenue $278.5K $3.293M
YoY Change -91.54% 3.72%
Gross Profit $3.653K $46.49K
YoY Change -92.14% -36.84%
Gross Profit Margin 1.29% 1.39%
Selling, General & Admin $43.41K $62.05K
YoY Change -30.04% 88.77%
% of Gross Profit 1188.34% 133.47%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $56.00 $55.00
YoY Change 1.82% -84.72%
% of Gross Profit 1.53% 0.12%
Operating Expenses $48.37K $70.30K
YoY Change -31.2% 67.22%
Operating Profit -$44.72K -$23.81K
YoY Change 87.81% -175.42%
Interest Expense $1.443K $1.443K
YoY Change 0.0% -96.49%
% of Operating Profit
Other Income/Expense, Net $46.10K $12.16K
YoY Change 278.98% -82.95%
Pretax Income $1.380K -$11.65K
YoY Change -111.85% -111.32%
Income Tax
% Of Pretax Income
Net Earnings $1.380K -$11.65K
YoY Change -111.85% -111.32%
Net Earnings / Revenue 0.49% -0.35%
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 5.022M shares 4.816M shares
Diluted Shares Outstanding 5.022M shares 4.816M shares

Balance Sheet

Concept 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $6.150K $4.650K
YoY Change 32.26% -87.57%
Cash & Equivalents $6.146K $4.646K
Short-Term Investments
Other Short-Term Assets $25.32K $18.96K
YoY Change 33.54% 161.88%
Inventory $2.140M $1.816M
Prepaid Expenses $25.32K $18.96K
Receivables
Other Receivables
Total Short-Term Assets $2.172M $1.840M
YoY Change 18.01% 18.87%
LONG-TERM ASSETS
Property, Plant & Equipment $147.00 $369.00
YoY Change -60.16% -98.42%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $33.01K $7.414K
YoY Change 345.21% -68.18%
TOTAL ASSETS
Total Short-Term Assets $2.172M $1.840M
Total Long-Term Assets $33.01K $7.414K
Total Assets $2.205M $1.848M
YoY Change 19.33% 17.58%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $558.5K $472.6K
YoY Change 18.2% -14.03%
Deferred Revenue
YoY Change
Short-Term Debt $73.52K $62.50K
YoY Change 17.63% -70.29%
Long-Term Debt Due $9.220K $5.870K
YoY Change 57.07% 122.35%
Total Short-Term Liabilities $677.6K $577.2K
YoY Change 17.39% -27.76%
LONG-TERM LIABILITIES
Long-Term Debt $140.8K $144.1K
YoY Change -2.32% -2.2%
Other Long-Term Liabilities $14.54K
YoY Change
Total Long-Term Liabilities $155.3K $144.1K
YoY Change 7.76% -6.66%
TOTAL LIABILITIES
Total Short-Term Liabilities $677.6K $577.2K
Total Long-Term Liabilities $155.3K $144.1K
Total Liabilities $832.9K $721.4K
YoY Change 15.46% -24.34%
SHAREHOLDERS EQUITY
Retained Earnings -$65.91M -$65.93M
YoY Change -0.03%
Common Stock $502.00 $481.00
YoY Change 4.37%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.372M $1.126M
YoY Change
Total Liabilities & Shareholders Equity $2.205M $1.848M
YoY Change 19.33% 17.58%

Cashflow Statement

Concept 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income $1.380K -$11.65K
YoY Change -111.85% -111.32%
Depreciation, Depletion And Amortization $56.00 $55.00
YoY Change 1.82% -84.72%
Cash From Operating Activities -$55.49K -$68.55K
YoY Change -19.05% 36.95%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $47.48K $56.50K
YoY Change -15.96% -1.4%
NET CHANGE
Cash From Operating Activities -$55.49K -$68.55K
Cash From Investing Activities
Cash From Financing Activities $47.48K $56.50K
Net Change In Cash -$8.004K -$12.05K
YoY Change -33.55%
FREE CASH FLOW
Cash From Operating Activities -$55.49K -$68.55K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
usd
CY2024Q1 dei Security12g Title
Security12gTitle
Common Stock.
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
5021857 shares
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6146 usd
CY2024Q1 SSOK Inventory Coins Current
InventoryCoinsCurrent
1277377 usd
CY2023Q4 SSOK Inventory Coins Current
InventoryCoinsCurrent
1272999 usd
CY2024Q1 SSOK Inventory Precious Metals Current
InventoryPreciousMetalsCurrent
862738 usd
CY2023Q4 SSOK Inventory Precious Metals Current
InventoryPreciousMetalsCurrent
814574 usd
CY2024Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
25318 usd
CY2024Q1 us-gaap Assets Current
AssetsCurrent
2171579 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
147 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
32861 usd
CY2024Q1 us-gaap Assets
Assets
2204587 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
576544 usd
CY2024Q1 us-gaap Loans Payable To Bank Current
LoansPayableToBankCurrent
9217 usd
CY2024Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
18320 usd
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
677604 usd
CY2024Q1 us-gaap Long Term Loans Payable
LongTermLoansPayable
140783 usd
CY2024Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
14541 usd
CY2024Q1 us-gaap Liabilities
Liabilities
832928 usd
CY2024Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5021857 shares
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5021857 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
5021857 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5021857 shares
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
502 usd
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
67279869 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-65908712 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1371659 usd
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2204587 usd
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
282138 usd
CY2024Q1 us-gaap Cost Of Revenue
CostOfRevenue
278485 usd
CY2023Q1 us-gaap Cost Of Revenue
CostOfRevenue
3293393 usd
CY2024Q1 us-gaap Gross Profit
GrossProfit
3653 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
46491 usd
CY2024Q1 us-gaap Professional Fees
ProfessionalFees
43406 usd
CY2023Q1 us-gaap Professional Fees
ProfessionalFees
62052 usd
CY2024Q1 us-gaap Other Expenses
OtherExpenses
4962 usd
CY2023Q1 us-gaap Other Expenses
OtherExpenses
8248 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
48368 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
70300 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-44715 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-23809 usd
CY2024Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
48164 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
14075 usd
CY2024Q1 us-gaap Interest Expense
InterestExpense
1443 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
1443 usd
CY2024Q1 SSOK Interest Expenses Related Party
InterestExpensesRelatedParty
626 usd
CY2023Q1 SSOK Interest Expenses Related Party
InterestExpensesRelatedParty
469 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
46095 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
12163 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1380 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-11646 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1380 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-11646 usd
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5021857 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5021857 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4815857 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4815857 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1137792 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-11646 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1126146 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1370279 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1370279 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1380 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1380 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1371659 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1371659 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
1380 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-11646 usd
CY2024Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
48164 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
14075 usd
CY2024Q1 us-gaap Depreciation
Depreciation
56 usd
CY2023Q1 us-gaap Depreciation
Depreciation
55 usd
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4378 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
50761 usd
CY2024Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
15991 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
13808 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
11611 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
21690 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-55486 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-68545 usd
CY2024Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
47482 usd
CY2023Q1 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
56500 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
47482 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
56500 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8004 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-12045 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
13790 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16691 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
6146 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4646 usd
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_847_eus-gaap--UseOfEstimates_zhLQsCu8YXLg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_z5YkCxdP4dWl">USE OF ESTIMATES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the unaudited condensed and consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates made by the Company’s management include realizability and valuation of inventories and value of stock-based transactions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
CY2024Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_848_eus-gaap--ConcentrationRiskCreditRisk_zI2hIoIciEo6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86C_zp6b5VW06VP2">CONCENTRATION OF RISK</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash. The Company places its cash with high quality banking institutions. The Company did not have cash balances in excess of the Federal Deposit Insurance Corporation limit as of March 31, 2024 and December 31, 2023.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
130000 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
133649 usd
CY2024Q1 SSOK Accrued Audit Fees Current
AccruedAuditFeesCurrent
28244 usd
CY2023Q4 SSOK Accrued Audit Fees Current
AccruedAuditFeesCurrent
14934 usd
CY2024Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
48164 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
14075 usd
CY2024Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2023Q1 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 usd
CY2024Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
36326 usd
CY2023Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
36326 usd
CY2024Q1 us-gaap Interest Payable Current
InterestPayableCurrent
21651 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
20208 usd
CY2024Q1 SSOK Accrued Interest Payable Related Party
AccruedInterestPayableRelatedParty
13352 usd
CY2023Q4 SSOK Accrued Interest Payable Related Party
AccruedInterestPayableRelatedParty
12726 usd
CY2024Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8800 usd
CY2024Q1 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2023Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0 usd
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-65908712 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8919 usd
CY2024Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
576544 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
564933 usd
CY2024Q1 us-gaap Dividends Payable Current
DividendsPayableCurrent
36326 usd
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
58460 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
58460 usd
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
58313 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
58257 usd
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
147 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
203 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
56 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
55 usd
CY2024Q1 SSOK Accrued Court Decision Current
AccruedCourtDecisionCurrent
338171 usd
CY2023Q4 SSOK Accrued Court Decision Current
AccruedCourtDecisionCurrent
338171 usd
CY2023Q3 SSOK Lawsuit Judgement
LawsuitJudgement
77863 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
23095 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
8940 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
8940 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
8940 usd
CY2024Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
8940 usd
CY2024Q1 SSOK Long Term Debt Maturities Repayments Of Principal After Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour
191465 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
250320 usd
CY2024Q1 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
100320 usd
CY2024Q1 us-gaap Loans Payable
LoansPayable
150000 usd
CY2024Q1 us-gaap Loans Payable Current
LoansPayableCurrent
9217 usd
CY2024Q1 us-gaap Long Term Loans Payable
LongTermLoansPayable
140783 usd
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P26Y2M12D
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2024Q1 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
0 shares
CY2023Q1 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
0 shares

Files In Submission

Name View Source Status
0001493152-24-019643-index-headers.html Edgar Link pending
0001493152-24-019643-index.html Edgar Link pending
0001493152-24-019643.txt Edgar Link pending
0001493152-24-019643-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
form10-q_htm.xml Edgar Link completed
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ssok-20240331.xsd Edgar Link pending
ssok-20240331_lab.xml Edgar Link unprocessable
ssok-20240331_def.xml Edgar Link unprocessable
ssok-20240331_pre.xml Edgar Link unprocessable
ssok-20240331_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable